Loading Events


ARDL runs events throughout the year in London, Manchester and Edinburgh.
The main events are seminars, Junior ARDL events, the AGM, the ARDL Dinner and the ARDL Annual Conference.
Members only

ARDL Bite Size Webinar: Pre-publication update on the new version of Good Medical Practice

Time: 18:00 - 18:45
Venue: Webinar via Zoom

This webinar is the final one in our Spring/Summer series of short bite size webinars, with just one speaker and lasting between 30-45 minutes.


Mark Swindells Assistant Director, Standards and Ethics at the General Medical Council

Mark is the Assistant Director for the Standards and Ethics team at the GMC. This team is responsible for the GMC’s core guidance for doctors: Good Medical Practice (GMP), and other guidance which builds on the principles in GMP. They produce learning materials and give advice on standards and ethics through the GMC’s enquiry service.

Prior to joining the GMC in 2018, Mark worked in the civil service, latterly as Head of Strategic Reform and Priorities at the Department for International Development. Prior to that he held a number of policy, operational and private office roles at the Department for Work and Pensions.


Fameeda Shafiq Managing Associate at Ward Hadaway LLP

Fameeda is a Managing Associate at Ward Hadaway in the Manchester office. She specialises in professional discipline, regulation and court of protection work. Fameeda has extensive experience in advising regulatory bodies and those who are regulated, particularly within the healthcare, social care and childcare sectors.

Fameeda is a steering committee member for the Asian Business Development Group at the Greater Manchester Chambers of Commerce.

Description: This is a confidential update for ARDL members on the upcoming new version of Good Medical Practice (GMP). The GMC consulted on proposed changes to GMP last year. Mark previously joined an ARDL ethics seminar in April 2022 ahead of that consultation. Mark will give some insights into what the GMC heard back in that consultation, and what those insights mean in terms of the new version of GMP when it is published.